Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma

Seunggu J. Han, John D. Rolston, Annette M. Molinaro, Jennifer L. Clarke, Michael D. Prados, Susan M. Chang, Mitchel S. Berger, Ashley DeSilva, Nicholas A. Butowski

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma'. Together they form a unique fingerprint.

Medicine & Life Sciences